Oscar Health (NYSE:OSCR) Earns Underperform Rating from Analysts at Jefferies Financial Group

Jefferies Financial Group initiated coverage on shares of Oscar Health (NYSE:OSCR) in a research note published on Tuesday morning, Marketbeat Ratings reports. The firm issued an underperform rating and a $12.00 price target on the stock.

A number of other research firms also recently weighed in on OSCR. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price for the company. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Trading Down 5.0 %

Shares of OSCR opened at $13.64 on Tuesday. The stock’s 50-day moving average price is $16.46 and its 200 day moving average price is $17.68. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 12-month low of $7.67 and a 12-month high of $23.79. The firm has a market capitalization of $3.37 billion, a price-to-earnings ratio of -227.33 and a beta of 1.64.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same period last year, the business earned ($0.29) earnings per share. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. As a group, research analysts predict that Oscar Health will post -0.01 earnings per share for the current year.

Insiders Place Their Bets

In other Oscar Health news, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of Oscar Health stock in a transaction dated Tuesday, November 12th. The shares were bought at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the purchase, the director now owns 5,452,081 shares of the company’s stock, valued at $74,584,468.08. This trade represents a 8.36 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of the stock in a transaction dated Monday, November 11th. The shares were acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now owns 5,031,262 shares in the company, valued at $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. State Street Corp grew its position in shares of Oscar Health by 6.0% during the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after buying an additional 291,335 shares during the period. Geode Capital Management LLC grew its holdings in Oscar Health by 11.7% during the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after purchasing an additional 455,205 shares during the period. Renaissance Technologies LLC grew its holdings in Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the period. Assenagon Asset Management S.A. increased its stake in Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after purchasing an additional 507,009 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Oscar Health by 20.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after purchasing an additional 270,223 shares during the period. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.